GENE ONLINE|News &
Opinion
Blog

2018-10-04| PartnerAsia-Pacific

【Event Information】Med x Tech Summit Asia (MEDTEX) will debut on Nov 29th – 30th in Taipei, Taiwan!

by GeneOnline
Share To

From AIoT, Blockchain, Gene Editing, Cell Therapy, to Immune-Oncology, MEDTEX brings over 30 cross-industry global key opinion leaders to Taipei.

MEDTEX welcomes world-renowned experts Including Microsoft, Google AI, Takeda, Mayo Clinic, Merck, Teva, Harvard Medical School, NVIDIA, etc. to discuss Immune-Oncology, Delivering Personalized Healthcare through Precision Medicine, Intelligent Healthcare, Blockchain, Big Data, and other popular topics in this intensive 2-day event.

Taiwan Healthcare+ Expo is the signature expo in Asia Pacific that provides solutions for medicine, health, and care. Starting from all aspects of healthcare needs, the expo strategically connects electronics, IT, biotech, pharmaceuticals, medical devices, precision machinery, precision medicine, health management industries along with the biomedical innovators from Israel, US, Germany, Singapore, Australia together.

With 400+ major medical centers, technology, pharmaceutical, medical devices organizations participating, MEDTEX and Healthcare+ Expo are for medical professionals, IT, device, pharmaceutical, and biotech companies who wants to find new opportunities and partnering with global healthcare industry players in Asia. All expo attendees also have the opportunity to participate in the optional B2B Partnering Program.

Don’t wait till its’ too late! Come and join us, register now!

Time: Nov 29 (Thur) – 30 (Fri)
Location: Grande Luxe Banquet (Flagship)
MEDTEX Info: https://bit.ly/2NUNbIg

 

©www.geneonline.com All rights reserved. Collaborate with us: service@geneonlineasia.com
Related Post
M&A
Merck Expands Hematology Portfolio With $1.35 Billion Imago Buy
2022-11-22
M&A
Johnson & Johnson Throws Down $16.6 billion for Abiomed
2022-11-01
Merck’s Streptococcus pneumoniae Expansion Finally Receives European Commission Approval
2022-10-24
LATEST
Pfizer To Invest $1.26 Billion In Irish Plant, Forms New Vant Company Targeting Inflammation
2022-12-02
Scientists Identify New Genetic Variant Related to Obesity
2022-12-01
Micronbrane Medical Aspires to Further Clinical Collaboration Following the Successful Series A Funding
2022-12-01
FDA Revokes Authorization Of Eli Lilly’s COVID-19 Antibody
2022-12-01
Eisai Unveils Lecanemab Data Following Reports of Second Alzheimer’s Patient Death
2022-11-30
New CRISPR/Cas9 license agreement for ERS Genomics and Cosmo Bio
2022-11-30
Gland Pharma Dispels Rumors Of Fosun Sale, Acquires Cenexi In Separate Development
2022-11-30
EVENT
2022-12-10
64TH ASH ANNUAL MEETING & EXPOSITION
New Orleans, USA
2022-12-14
BIOHK2022
Hong Kong, China
2023-01-07
7th Asia Microbiome Conference
Taipei, Taiwan
Scroll to Top

Create an account with us now to say goodbye to all the pop-ups!